Company intelligence / Profile preview

Tolmar Therapeutics

Buffalo Grove, Illinois, United States
Ownership
Private
Employees
~800
Development stage
Other
01

Overview

Tolmar is a fully integrated specialty pharmaceutical company focused on the development, manufacturing, and commercialization of innovative therapeutic solutions in urology, oncology, and dermatology. The company is best known for its proprietary ATRIGEL Delivery System, a biodegradable polymer-based technology that enables the sustained release of therapeutic agents over extended periods. Tolmar's flagship product, ELIGARD (leuprolide acetate), is a leading treatment for advanced prostate cancer. Headquartered in the United States, the company maintains significant research, development, and state-of-the-art manufacturing facilities to support its global commercial operations.

Therapeutic areas
OncologyEndocrinologyDermatology
Modalities
Small moleculePeptidesHormoneHydrogel-based drug delivery therapy
Industry
Biotech
02

Partnerships

SanofiDNDi (Drugs for Neglected Diseases initiative)Recordati

Beyond the preview

Go deeper on Tolmar Therapeutics.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Full profile access

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Full profile access

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Full profile access

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Full profile access

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Full profile access

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Tolmar Therapeutics.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call